Aptamer‐Incorporated Nanoparticle Systems for Drug Delivery

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Unknown venue

• Publication date

  2020-11-17

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1002/9781119671732.ch5
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Lipid–polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives

  2019cited by this paper
• Smart aptamer-modified calcium carbonate nanoparticles for controlled release and targeted delivery of epirubicin and melittin into cancer cells in vitro and in vivo

  2019cited by this paper
• Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer Cells

  2019cited by this paper
• Lipid-polymer nanoparticles with CD133 aptamers for targeted delivery of all-trans retinoic acid to osteosarcoma initiating cells.

  2019cited by this paper
• A novel MUC1 aptamer-modified PLGA-epirubicin-PβAE-antimir-21 nanocomplex platform for targeted co-delivery of anticancer agents in vitro and in vivo.

  2019cited by this paper
• Enhanced Lysosomal Escape of pH-Responsive Polyethylenimine-Betaine Functionalized Carbon Nanotube for the Codelivery of Survivin Small Interfering RNA and Doxorubicin.

  2019cited by this paper
• Peptide-Based Drug-Delivery Systems in Biotechnological Applications: Recent Advances and Perspectives

  2019cited by this paper
• Selective chemotherapy and imaging of colorectal and breast cancer cells by a modified MUC-1 aptamer conjugated to a poly(ethylene glycol)-dimethacrylate coated Fe3O4–AuNCs nanocomposite

  2019cited by this paper
• Peptide-Aptamer Coassembly Nanocarrier for Cancer Therapy.

  2019cited by this paper
• Duplexed aptamers: history, design, theory, and application to biosensing.

  2019cited by this paper
• Conjugation of prostate cancer-specific aptamers to polyethylene glycol-grafted polyethylenimine for enhanced gene delivery to prostate cancer cells

  2019cited by this paper
• Chitosan-Modified PLGA Nanoparticles for Control-Released Drug Delivery

  2019cited by this paper
• A Novel AS1411 Aptamer-Based Three-Way Junction Pocket DNA Nanostructure Loaded with Doxorubicin for Targeting Cancer Cells in Vitro and in Vivo.

  2018cited by this paper
• Nano-selenium and its nanomedicine applications: a critical review

  2018cited by this paper
• MUC1 aptamer-conjugated mesoporous silica nanoparticles effectively target breast cancer cells

  2018cited by this paper
• A Promising Biocompatible Platform: Lipid-Based and Bio-Inspired Smart Drug Delivery Systems for Cancer Therapy

  2018cited by this paper
• Multivalent aptamer-modified tetrahedral DNA nanocage demonstrates high selectivity and safety for anti-tumor therapy.

  2018cited by this paper
• Self-Assembled Aptamer-Grafted Hyperbranched Polymer Nanocarrier for Targeted and Photoresponsive Drug Delivery.

  2018cited by this paper
• Chitosan-Based Nanomaterials for Drug Delivery

  2018cited by this paper
• Targeted delivery of doxorubicin to cancer cells by a cruciform DNA nanostructure composed of AS1411 and FOXM1 aptamers

  2018cited by this paper
• Curcumin‐entrapped MUC‐1 aptamer targeted dendrimer‐gold hybrid nanostructure as a theranostic system for colon adenocarcinoma

  2018cited by this paper
• pH-Control in Aptamer-Based Diagnostics, Therapeutics, and Analytical Applications

  2018cited by this paper
• Targeted co-delivery of epirubicin and NAS-24 aptamer to cancer cells using selenium nanoparticles for enhancing tumor response in vitro and in vivo.

  2018cited by this paper
• Fabrication of acetylated carboxymethylcellulose coated hollow mesoporous silica hybrid nanoparticles for nucleolin targeted delivery to colon adenocarcinoma.

  2018cited by this paper
• Aptamer–drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity

  2018cited by this paper
• Reformulating acute myeloid leukemia: liposomal cytarabine and daunorubicin (CPX-351) as an emerging therapy for secondary AML

  2018cited by this paper
• Multi-functionalized chitosan nanoparticles for enhanced chemotherapy in lung cancer.

  2018cited by this paper
• Nucleolin-Targeting AS1411-Aptamer-Modified Graft Polymeric Micelle with Dual pH/Redox Sensitivity Designed To Enhance Tumor Therapy through the Codelivery of Doxorubicin/TLR4 siRNA and Suppression of Invasion.

  2018cited by this paper
• Gold nanoparticle should understand protein corona for being a clinical nanomaterial

  2018cited by this paper
• CD133-targeted delivery of self-assembled PEGylated carboxymethylcellulose-SN38 nanoparticles to colorectal cancer

  2018cited by this paper
• MUC1 aptamer-targeted DNA micelles for dual tumor therapy using doxorubicin and KLA peptide.

  2018cited by this paper
• Targeted delivery of melittin to cancer cells by AS1411 anti-nucleolin aptamer

  2018cited by this paper
• Design strategies for physical-stimuli-responsive programmable nanotherapeutics.

  2018cited by this paper
• Identification and imaging of leukemia cells using dual-aptamer-functionalized graphene oxide complex

  2017cited by this paper
• Anti‐MUC1 aptamer: A potential opportunity for cancer treatment

  2017cited by this paper
• Doxorubicin Loaded DNA Aptamer Linked Myristilated Chitosan Nanogel for Targeted Drug Delivery to Prostate Cancer

  2017cited by this paper
• A new chemotherapy agent-free theranostic system composed of graphene oxide nano-complex and aptamers for treatment of cancer cells.

  2017cited by this paper
• Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-co-glycolic acid) nanobubbles for ultrasound imaging and therapy of prostate cancer

  2017cited by this paper
• Suppression of FOXM1 Transcriptional Activities via a Single-Stranded DNA Aptamer Generated by SELEX

  2017cited by this paper
• Characterization of the specific interaction between the DNA aptamer sgc8c and protein tyrosine kinase-7 receptors at the surface of T-cells by biosensing AFM

  2017cited by this paper
• Inhibition of DNA replication by an anti-PCNA aptamer/PCNA complex

  2017cited by this paper
• Epidermal growth factor receptor aptamer-conjugated polymer-lipid hybrid nanoparticles enhance salinomycin delivery to osteosarcoma and cancer stem cells

  2017cited by this paper
• Near infrared light-controlled therapeutic molecules release of nanocarriers in cancer therapy

  2017cited by this paper
• Peptide-Based Stealth Nanoparticles for Targeted and pH-Triggered Delivery.

  2017cited by this paper
• Aptamer-modified nanomaterials: principles and applications

  2017cited by this paper
• Aptamer-coded DNA nanoparticles for targeted doxorubicin delivery using pH-sensitive spacer

  2017cited by this paper
• A novel aptamer-based DNA diamond nanostructure for in vivo targeted delivery of epirubicin to cancer cells

  2017cited by this paper
• Aptamer-anchored di-polymer shell-capped mesoporous carbon as a drug carrier for bi-trigger targeted drug delivery.

  2017cited by this paper
• Aptamer-Modified Tetrahedral DNA Nanostructure for Tumor-Targeted Drug Delivery.

  2017cited by this paper
• PLGA nanoparticles with CD133 aptamers for targeted delivery and sustained release of propranolol to hemangioma.

  2017cited by this paper
• Targeted Delivery of Epirubicin to Cancer Cells by Polyvalent Aptamer System in vitro and in vivo

  2016cited by this paper
• Aptamer-Functionalized and Backbone Redox-Responsive Hyperbranched Polymer for Targeted Drug Delivery in Cancer Therapy.

  2016cited by this paper
• Double targeting, controlled release and reversible delivery of daunorubicin to cancer cells by polyvalent aptamers-modified gold nanoparticles.

  2016cited by this paper
• Aptamers as targeted therapeutics: current potential and challenges

  2016cited by this paper
• A FRET-guided, NIR-responsive bubble-generating liposomal system for in vivo targeted therapy with spatially and temporally precise controlled release.

  2016cited by this paper
• Advancements in Aptamer Discovery Technologies.

  2016cited by this paper
• Double targeting and aptamer-assisted controlled release delivery of epirubicin to cancer cells by aptamers-based dendrimer in vitro and in vivo.

  2016cited by this paper
• Meta-analysis of clinical and preclinical studies comparing the anticancer efficacy of liposomal versus conventional non-liposomal doxorubicin.

  2016cited by this paper
• Gold nanoparticle-DNA aptamer conjugate-assisted delivery of antimicrobial peptide effectively eliminates intracellular Salmonella enterica serovar Typhimurium.

  2016cited by this paper
• Near-infrared light-activated cancer cell targeting and drug delivery with aptamer-modified nanostructures

  2015cited by this paper
• Epithelial cell adhesion molecule aptamer conjugated PEG-PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro.

  2015cited by this paper
• Aptamer density dependent cellular uptake of lipid-capped polymer nanoparticles for polyvalent targeted delivery of vinorelbine to cancer cells

  2015cited by this paper
• Aptamers and their applications in nanomedicine.

  2015cited by this paper
• DNA-Aptamer Targeting Vimentin for Tumor Therapy In Vivo

  2014cited by this paper
• Aptamer-Targeted DNA Nanostructures for Therapeutic Delivery

  2014cited by this paper
• The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization.

  2014cited by this paper
• AS1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA-PCL-pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy.

  2014cited by this paper
• Stimuli-responsive nanocarriers for drug delivery.

  2013cited by this paper
• Epirubicin loaded super paramagnetic iron oxide nanoparticle-aptamer bioconjugate for combined colon cancer therapy and imaging in vivo.

  2013cited by this paper
• Aptamer-labeled PLGA nanoparticles for targeting cancer cells

  2012cited by this paper
• Doxil®--the first FDA-approved nano-drug: lessons learned.

  2012cited by this paper
• Aptamer-conjugated and drug-loaded acoustic droplets for ultrasound theranosis.

  2012cited by this paper
• AS1411 aptamer tagged PLGA‐lecithin‐PEG nanoparticles for tumor cell targeting and drug delivery

  2012cited by this paper
• Poly(Ethylene Glycol) in Drug Delivery, Why Does it Work, and Can We do Better? All Atom Molecular Dynamics Simulation Provides Some Answers

  2012cited by this paper
• Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery.

  2011cited by this paper
• Rational Truncation of an RNA Aptamer to Prostate-Specific Membrane Antigen Using Computational Structural Modeling

  2011cited by this paper
• PEGylated anti-MUC1 aptamer-doxorubicin complex for targeted drug delivery to MCF7 breast cancer cells.

  2011cited by this paper
• Aptamer-conjugated DNA icosahedral nanoparticles as a carrier of doxorubicin for cancer therapy.

  2011cited by this paper
• Polymers for drug delivery systems.

  2010cited by this paper
• Aptamers for Targeted Drug Delivery

  2010cited by this paper
• Directed evolution of gold nanoparticle delivery to cells.

  2010cited by this paper
• In vitro derby imaging of cancer biomarkers using quantum dots.

  2009cited by this paper
• Aptamers selected against the unglycosylated EGFRvIII ectodomain and delivered intracellularly reduce membrane-bound EGFRvIII and induce apoptosis

  2009cited by this paper
• DNA aptamer–micelle as an efficient detection/delivery vehicle toward cancer cells

  2009cited by this paper
• Cell-specific aptamer probes for membrane protein elucidation in cancer cells.

  2008cited by this paper
• Bifunctional recombinant proteins in cancer therapy: cell penetrating peptide aptamers as inhibitors of growth factor signaling

  2003cited by this paper
• Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen.

  2002cited by this paper
• Poly(ethylene glycol)–polyethyleneimine NanoGel™ particles: novel drug delivery systems for antisense oligonucleotides

  1999cited by this paper
• Liposome-anchored vascular endothelial growth factor aptamers.

  1998cited by this paper

• Targeted delivery of galbanic acid to colon cancer cells by PLGA nanoparticles incorporated into human mesenchymal stem cells

  2022cites this paper
• Mitoxantrone-Loaded PLGA Nanoparticles for Increased Sensitivity of Glioblastoma Cancer Cell to TRAIL-Induced Apoptosis

  2021cites this paper
• Synthesis of a Therapeutic Amphiphilic Copolymer of SN38 via RAFT Polymerization and Its Self-Assembly to Peptomicelles for Fighting against Colon Adenocarcinoma

  2021cites this paper
• Mitoxantrone-Loaded PLGA Nanoparticles for Increased Sensitivity of Glioblastoma Cancer Cell to TRAIL-Induced Apoptosis

  2021cites this paper